Cervical squamous intraepithelial lesions among HIV-positive women on antiretroviral therapy in Kenya

Current HIV Research

Volumn 9, Issue 3, 2011, Pages 180-185

  McKenzie, Kevin P ^a   Rogers, Robyn K ^a   Njoroge, Julia W ^a   John Stewart, Grace ^a   Richardson, Barbra A ^a,b   Mugo, Nelly R ^c   de Vuyst, Hugo ^d   Pamnani, Ritesh N ^e   Rana, Farzana S ^f   Warui, Danson ^g   Chung, Michael H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c KENYATTA NATIONAL HOSPITAL   (Kenya)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e UNIVERSITY OF NAIROBI   (Kenya)

^f AGA KHAN UNIVERSITY   (Kenya)

^g Internal Medicine and Critical care Department   (Kenya)

Author keywords

Africa; Antiretroviral therapy; Cervical squamous intraepithelial lesions; HIV; Women

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CANCER GRADING; CANCER SCREENING; CD4 LYMPHOCYTE COUNT; CONDOM; CORRELATION ANALYSIS; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; KENYA; LOGISTIC REGRESSION ANALYSIS; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT EDUCATION; PREVALENCE; SEXUAL BEHAVIOR; TREATMENT DURATION; UNIVARIATE ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONDOMS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE TOLERANCE; KENYA; NEOPLASMS, SQUAMOUS CELL; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 79959305695     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016211795945214     Document Type: Article

References (34)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37 Suppl 8: S4-66.
2. Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H. Part I: Cancer in Indigenous Africans-burden, distribution, and trends. Lancet Oncol 2008 Jul; 9(7): 683-92.
3. Gichangi P, De Vuyst H, Estambale B, Rogo K, Bwayo J, Temmerman M. HIV and cervical cancer in Kenya. Int J Gynaecol Obstet 2002; 76(1): 55-63.
4. Gichangi P, Estambale B, Bwayo J, et al. Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya. Int J Gynecol Cancer 2003; 13(6): 827-33.
5. De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev 2008; 17(6): 545-54.
6. Franceschi S, Jaffe H. Cervical cancer screening of women living with HIV infection: a must in the era of antiretroviral therapy. Clin Infect Dis 2007; 45(4): 510-3.
7. Paramsothy P, Jamieson DJ, Heilig CM, et al. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol 2009; 113(1): 26-31.
8. Del Mistro A, Bertorelle R, Franzetti M, et al. Antiretroviral therapy and the clinical evolution of human papillomavirusassociated genital lesions in HIV-positive women. Clin Infect Dis 2004; 38(5): 737-42.
9. Heard I, Tassie JM, Kazatchkine MD, Orth G. Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS 2002; 16(13): 1799-802.
10. Guiguet M, Boue F, Cadranel J, Lang JM, Rosenthal E, Costagliola D. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009; 10(12): 1152-9.
11. Chung MH, Drake AL, Richardson BA, et al. Impact of prior HAART use on clinical outcomes in a large Kenyan HIV treatment program. Curr HIV Res 2009; 7(4): 441-6.
12. Ojoo S, editor. Kenya National Clinical Manual for ART Providers: A Concise and Practical Guide to ART Provision. 2nd ed. Nairobi: National AIDS and STI Control Program (NASCOP); 2007.
13. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287(16): 2114-9.
14. Yamada R, Sasagawa T, Kirumbi LW, et al. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J Med Virol 2008; 80(5): 847-55.
15. Agaba PA, Thacher TD, Ekwempu CC, Idoko JA. Cervical dysplasia in Nigerian women infected with HIV. Int J Gynaecol Obstet 2009; 107(2): 99-102.
16. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, et al. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006; 103(3): 1017-22.
17. Palefsky J. Biology of HPV in HIV infection. Adv Dent Res 2006; 19(1): 99-105.
18. Davis AT, Chakraborty H, Flowers L, Mosunjac MB. Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4+ count. Gynecol Oncol 2001; 80(3): 350-4.
19. Minkoff H, Zhong Y, Burk RD, et al. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women. J Infect Dis 2010; 201(5): 681-90.
20. Lillo FB, Ferrari D, Veglia F, et al. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 2001; 184(5): 547-51.
21. Boardman LA, Cotter K, Raker C, Cu-Uvin S. Cervical intraepithelial neoplasia grade 2 or worse in human immunodeficiency virus-infected women with mildly abnormal cervical cytology. Obstet Gynecol 2008; 112(2 Pt 1): 238-43.
22. Denny L, Boa R, Williamson AL, et al. Human papillomavirus infection and cervical disease in human immunodeficiency virus-1- infected women. Obstet Gynecol 2008; 111(6): 1380-7.
23. Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer 2003; 105(5): 687-91.
24. Mangclaviraj S, Kerr SJ, Chaithongwongwatthana S, et al. Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting. Int J STD AIDS 2008; 19(8): 529-32.
25. Shannon J, Thomas DB, Ray RM, et al. Dietary risk factors for invasive and in-situ cervical carcinomas in Bangkok, Thailand. Cancer Cause Control 2002; 13(8): 691-9.
26. Hwang JH, Kim MK, Lee JK. Dietary supplements reduce the risk of cervical intraepithelial neoplasia. Int J Gynecol Cancer 2010; 20(3): 398-403.
27. Velema JP, Ferrera A, Figueroa M, et al. Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras. Int J Cancer 2002; 97(4): 536-41.
28. Pereira DB, Antoni MH, Danielson A, et al. Life stress and cervical squamous intraepithelial lesions in women with human papillomavirus and human immunodeficiency virus. Psychosom Med 2003; 65(3): 427-34.
29. Hernandez BY, Wilkens LR, Zhu X, et al. Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis 2008; 14(6): 888-94.
30. Mayaud P, Gill DK, Weiss HA, et al. The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Sex Transm Infect 2001; 77(4): 248-54.
31. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354(25): 2645-54.
32. Coker AL, Sanders LC, Bond SM, Gerasimova T, Pirisi L. Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development. J Womens Health Gend Based Med 2001; 10(5): 441-9.
33. Lomalisa P, Smith T, Guidozzi F. Human immunodeficiency virus infection and invasive cervical cancer in South Africa. Gynecol Oncol 2000; 77(3): 460-3.
34. Gichangi PB, Bwayo J, Estambale B, et al. Impact of HIV infection on invasive cervical cancer in Kenyan women. AIDS 2003; 17(13): 1963-8.